Gratus Capital LLC Eli Lilly & CO Transaction History

Gratus Capital LLC

$2.39 Billion
Q2 2024

A detailed history of Gratus Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Gratus Capital LLC holds 4,741 shares of LLY stock, worth $4.22 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

4,741

Previous 4,390 8.0%

Holding current value

$4.22 Million

Previous $3.42 Million 25.68%

% of portfolio

0.18%

Previous 0.16%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$724.87 - $909.04 $254,429 - $319,073	351 Added 8.0%	4,741 $4.29 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $772,821 - $1.03 Million	1,305 Added 42.3%	4,390 $3.42 Million
Q4 2023 Feb 07, 2024	SELL	$525.19 - $619.13 $105,563 - $124,445	-201 Reduced 6.12%	3,085 $1.8 Million
Q3 2023 Oct 26, 2023	BUY	$434.7 - $599.3 $103,023 - $142,034	237 Added 7.77%	3,286 $1.77 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $35,074 - $46,898	-100 Reduced 3.18%	3,049 $1.43 Million
Q1 2023 Apr 19, 2023	SELL	$310.63 - $364.82 $563,482 - $661,783	-1,814 Reduced 36.55%	3,149 $1.08 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $22,508 - $26,226	70 Added 1.43%	4,963 $0
Q3 2022 Nov 03, 2022	BUY	$296.48 - $337.87 $32,019 - $36,489	108 Added 2.26%	4,893 $1.58 Million
Q2 2022 Jul 29, 2022	BUY	$278.73 - $327.27 $2,508 - $2,945	9 Added 0.19%	4,785 $1.55 Million
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $2,346 - $2,916	10 Added 0.21%	4,776 $1.37 Million
Q4 2021 Jan 31, 2022	BUY	$224.85 - $279.04 $24,508 - $30,415	109 Added 2.34%	4,766 $1.32 Million
Q3 2021 Nov 05, 2021	BUY	$221.6 - $272.71 $78,224 - $96,266	353 Added 8.2%	4,657 $1.08 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $1,805 - $2,335	10 Added 0.23%	4,304 $988,000
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $37,136 - $48,074	-226 Reduced 5.0%	4,294 $802,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $32,484 - $42,984	249 Added 5.83%	4,520 $763,000
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $109,518 - $126,678	-749 Reduced 14.92%	4,271 $632,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $1,773 - $2,134	13 Added 0.26%	5,020 $824,000
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $714 - $884	6 Added 0.12%	5,007 $695,000
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $4,169 - $5,164	-39 Reduced 0.77%	5,001 $657,000
Q3 2019 Oct 30, 2019	BUY	$106.79 - $116.16 $1,708 - $1,858	16 Added 0.32%	5,040 $564,000
Q2 2019 Aug 07, 2019	BUY	$110.79 - $129.32 $1,551 - $1,810	14 Added 0.28%	5,024 $557,000
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $33,726 - $39,699	303 Added 6.44%	5,010 $650,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $137,670 - $154,232	-1,300 Reduced 21.64%	4,707 $545,000
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $139,046 - $155,774	1,313 Added 27.97%	6,007 $695,000
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $25,242 - $31,549	294 Added 6.68%	4,694 $504,000
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $1,362 - $1,563	18 Added 0.41%	4,400 $375,000
Q1 2018 May 10, 2018	BUY	$74.21 - $87.6 $325,188 - $383,863	4,382 New	4,382 $339,000

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $847B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gratus Capital LLC with notifications on news.

Account

Gratus Capital LLC Eli Lilly & CO Transaction History